"Mark, Todd, and Zola came to law school to change the world, to make it a better place. But now, as third-year students, these close friends realize they have been duped. They all borrowed heavily to attend a third-tier, for-profit law school so mediocre that its graduates rarely pass the bar exam, let alone get good jobs. And when they learn that their school is one of a chain owned by a shady New York hedge-fund operator who also happens to own...

Lacy Stoltz is an investigator for the Florida Board on Judicial Conduct. She is a lawyer, not a cop, and it is her job to respond to complaints dealing with judicial misconduct. After nine years with the Board, she knows that most problems are caused by incompetence, not corruption. But a corruption case eventually crosses her desk. A previously disbarred lawyer is back in business with a new identity. He now goes by the name Greg Myers, and he claims...

Big Oil and Gas versus democracy -- winner take all. In 2010, the words "earthquake swarm" entered the lexicon in Oklahoma. That same year, a trove of Michael Jackson memorabilia -- including his iconic crystal-encrusted white glove -- was sold at auction for over $1 million to a guy who was, officially, just the lowly forestry minister of the tiny nation of Equatorial Guinea. And in 2014, Ukrainian revolutionaries raided the palace of their ousted...

"How-to, authoritative guidance for creating a best-in-class fraud prevention and compliance program in any organizationNow in a Second Edition, this practical book helps corporate executives and managers understand the full ramifications of good corporate governance and compliance. It covers best practices for establishing a unit to protect the financial integrity of a business; theories and models on how and why fraud occurs in an organization;...

"While the pharmaceutical industry can play an important role in converting the knowledge generated by the Human Genome Project into new medicines, it also faces a popular perception that it is simply out to make money by promoting unsafe medicines to an unsuspecting public. Written by former Pfizer president John LaMattina, this book addresses the progress that the industry has made in improving its abilities to measure both the risk and benefits...